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Abstract
Background: In 1992, the concept of female athlete triad was introduced to describe the interrelated problems of amenorrhea,
eating disorders and osteoporosis seen in female athletes. To gain a clearer picture of amenorrhea/oligomenorrhea in Iran, one
of the main components of the female athlete triad, we therefore established this study on the prevalence of amenorrhea/
oligomenorrhea in elite Iranian female athletes, also evaluating the risk factors of these disorders in the same population.
Methods: This study performed as a cross-sectional study. All elite Iranian female athletes of 34 sports federation, including
female athletes in national teams and medalists of Tehran were invited to participate. A total of 788 (95% response rate)
returned the questionnaires and were examined. Younger athletes under the age of menarche were excluded. Each athlete
completed a self-administered questionnaire, which covered the following questions about participant's demographic
information, athletic history, history of injuries and menstrual pattern. In order to diagnose the causes of amenorrhea/
Oligomenorrhea including polycystic ovary syndrome(PCOS), participants with amenorrhea/Oligomenorrhea underwent
further investigation. They were evaluated by following Para clinic investigation, and an ultrasonographic study of ovary.
Results: The age ranged from 13–37 (mean = 21.1, SD = 4.5). Seventy one (9.0%) individuals had amenorrhea/oligomenorrhea,
among those, 11 (15.5%) had PCOS.
There was also a positive association between amenorrhea/oligomenorrhea and the following: age under 20 OR; 2.67,
95%CI(1.47 – 4.85), weight class sports OR; 2.09, 95%CI(1.15 – 3.82), endurance sports OR; 2.89, 95%CI(1.22 – 6.84), late onset
of menarche OR; 3.32 95%CI(1.04–10.51), and use of oral contraceptive pills OR; 6.17, 95%CI(3.00 – 12.69). Intensity of training
sport or BMI were not risk factors.
Conclusion: These findings support the previous findings in the literature that the prevalence of amenorrhea/oligomenorrhea
is high in athletes. Furthermore, we provided the first report on the prevalence of PCOS in female athletes with amenorrhea/
oligomenorrhea. Athletes would be greatly benefited by greater general awareness about the complications of amenorrhea/
oligomenorrhea.
To increase awareness of exercise-associated menstrual cycle irregularities, it is necessary to design complete and 
comprehensive education programs for female athletes, their parents, their coaches, and the relevant authorities.
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Background
Menstrual disorders such as amenorrhea/oligomenorrhea
depend on many factors, including race, genetic make-up,
BMI, and family history. However, the literature also
shows that amenorrhea/oligomenorrhea is more preva-
lent among athletes than in the general population [1,2].
Despite discrepancies in the reported frequencies, which
are attributable mainly to different definitions of amenor-
rhea/oligomenorrhea, unreported minor menstrual irreg-
ularities, and selection bias [2], this is commonly
accepted.
To our knowledge, no study has evaluated amenorrhea/
oligomenorrhea in Iranian female athletes, a group that is
particularly interesting because the nature and practice of
women's sports differ from those in the majority of other
countries. This is due partly to the fact that women's pro-
fessional sports – in the sense that sport is a woman's
main profession – have almost no place in Iran.
More importantly, however, it is a consequence of the reli-
gious dress code after Iran's 1979 Islamic revolution,
which requires women to cover all their hair, and to wear
long, loose-fitting clothes that disguise the shape of their
bodies. The code has presented Iranian sportswomen with
various difficulties: those competing in international
events have to respect it just as much as they respect rules
of their sport. Sports that require tight-fitting clothing –
for example, ballet, figure skating, swimming and syn-
chronized swimming – are not open to them at all.
The relevance of their position becomes clear when juxta-
posed with the Stand Position classification of the Ameri-
can College of Sports Medicine [3], according to which the
risk of menstrual disorders is higher in Sports in which
performance is subjectively scored or athletes who wear
body-contour-revealing clothing, are categorized on the
basis of their body weight, and practice endurance sports
the sports that are represented less in Iran.
In view of these differences, we wished to establish
whether the restrictions that apply to female athletes in
Iran influence the frequency and risk factors of amenor-
rhea/oligomenorrhea relative to those in other countries.
Even though female sport is much less professionalized in
Iran than elsewhere, competitive sports are becoming
increasingly important, as evidenced by women's pres-
ence in national competitions and in Islamic and few
international games.
Since exercise-associated menstrual cycle irregularities are
a threat to athletes' health, appropriate policy-making is
required on the part of the sport authorities, especially
those involved in women's sports. In 1992, the concept of
female athlete triad was introduced to describe the inter-
related problems of amenorrhea, eating disorders and
osteoporosis seen in female athletes [4]. To gain a clearer
picture of amenorrhea/oligomenorrhea, one of the main
components of the female athlete triad, we therefore
established this study on the prevalence of amenorrhea/
oligomenorrhea in elite Iranian female athletes, also eval-
uating the risk factors of these disorders in the same pop-
ulation.
Methods
Study population
This study performed as a cross-sectional study, which
took place in 2007–2008. All elite Iranian female athletes
of 34 sports federation, including female athletes in
national teams and Tehran's medalists were invited to par-
ticipate in this study. Written informed consent was
obtained from all participants.
To include all possible female athletes, we acquired the
time-tables of the national sports' camps in different fields
of sport and arranged for a visit. We also arranged an
appointment with Tehran's medalists after contacting
their coaches via written letters. A pre-designed structured
questionnaire was handed to participants before/after
training in the sport halls. A total of 830 participants were
invited of whom 788 (95%) returned the questionnaires
and were examined. Younger athletes under the age of
menarche were excluded from this study.
Measurements
Three specialists in sports medicine evaluated a pre-
designed questionnaire. After conduction of a pilot study
and implementation of necessary changes in the question-
naire, it has been used for the present study. This ques-
tionnaire covers the following questions about
participant's demographic information, athletic history,
history of injuries and menstrual pattern. Menstrual pat-
tern includes information about the age of menarche,
between cycles' gap, number of cycles in a year, and the
longest gap between two cycles in the previous year.
Details on history of menstrual dysfunction and any use
of hormonal medicine in last year were also recorded.
After filling questionnaires by participants, the question-
naire was scanned and controlled for any error or missing
item by responsible physician (HD). She (HD) also exam-
ined all participants for presence of acne or hirsutism. The
questions regarding menstrual pattern were specifically
checked in the case of any uncertainty, and re-enquired.
In order to diagnose the causes of amenorrhea/Oligomen-
orrhea including hyperprolactinemia, hypothyroidism,
and polycystic ovary disorders [PCOS]), participants with
amenorrhea/Oligomenorrhea underwent further investi-
gation. They were evaluated by following Para clinic
investigation; measurements of Serum follicle stimulatingSports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2009, 1:16 http://www.smarttjournal.com/content/1/1/16
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hormone (FSH), luteinizing hormone (LH), Thyroid
Stimulating Hormone (TSH), Prolactin, Free T4, Serum
testosterone and Dehydroepiandrosterone (DHEA) and
an ultrasonographic study of ovary.
Demographic characteristics
Age, education, height and weight were recorded on the
questionnaire. Participants were assessed in two age cate-
gories; under the age of 20 and over 20 years old. BMI was
calculated as weight in kilograms/height in square meters
and was evaluated in three categories; BMI less than 20,
BMI = 20 to 25 (normal group as the reference group) and
BMI over 25. Education were evaluated in three categories;
High school (under graduate), High school graduated and
Bachelor degree.
Primary amenorrhea
menarche has not been occurred by age 14 in the absence
of secondary sexual characteristics, or by 16 years of age in
the presence of normal growth and secondary sexual char-
acteristics[5].
Secondary amenorrhea
Menses have ceased at a point in time beyond establish-
ment of regular menstrual cycles. In this study, secondary
amenorrhea described as absence of at least 3 to 6 consec-
utive menstrual cycles or four or fewer menstrual period
per year.[5]
Oligomenorrhea
Menstrual cycles fewer than 8 cycles per year, or the dura-
tion of the cycle exceeds 35 days [5].
Late-onset menarche
Menarche occurred after the age of 16 [5].
Polycystic ovary syndrome (PCOS)
The 2003 Rotterdam consensus workshop concluded that
PCOS is a syndrome of ovarian dysfunction along with
the cardinal features; hyperandrogenism and poly cystic
ovary morphology. PCOS is diagnosed with presence of
two or three following criteria (a) chronic anovulation or
oligo-ovulation,(b) biochemical or clinical evidence of
androgen excess, and (c) presence of polycystic ovaries on
ultrasound [6].
Acne
is a chronic inflammatory disease of the Pilosebaceous
Unit. It is characterized by Seborrhoea, the formation of
comedones, erythematous papules and pustules, less fre-
quency by nodules, deep postules or pseudocysts and in
some cases is accompanied by scarring [7].
Hirsutism
Hirsutism in women defined as excessive thick (terminal)
hair growth in facial and body regions [8].
Drug intake
Participants were asked to record regular use of any med-
icine in the past year. Medicines were evaluated in three
groups: 1-Oral contraceptives pills (OCPs), 2-Diuretics
and/or weight-reducing drugs, 3-Thyroid hormones.
Sports classification
According to the Stand position classification of American
College of Sports Medicine potentially all physically active
girls and women could be at risk for developing one or
more components of the Triad (amenorrhea/oligomenor-
rhea, eating disorders and osteoporosis). Participation in
sports that emphasize low body weight can be a risk fac-
tor. Those sports include:
1. Sports in which performance is subjectively scored
(dance, figure skating, diving, gymnastics, aerobics). 2.
Endurance sports emphasizing a low body weight (dis-
tance running, cycling, cross-country skiing). 3. Sports
requiring body contour-revealing clothing for competi-
tion (volleyball, swimming, diving, cross-country run-
ning, cross-country skiing, and track) 4. Sports using
weight categories for participation (horse racing, some
martial arts, wrestling, rowing). 5. Sports emphasizing a
prepubertal body habitus for performance success (figure
skating, gymnastics, diving) [3].
Sport intensity: Intensity of sport were calculated as hours
of training sport in a week (Hours per week).
Statistical analysis
Quantitative data were described by mean and standard
deviation and qualitative data by frequency. T-test and
chi-square were used to compare quantitative and qualita-
tive data respectively. Fischer's test was used when appro-
priate. Univariate logistic regression analysis was used
initially to examine associations between Amenorrhea/
Oligomenorrhea and potential risk factor. The following
independent variables were evaluated in the univariate
model separately: age, age of menarche, BMI, use of ster-
oidal hormones, diuretics/weight-reducing drugs and thy-
roid hormones, and type of sports. The factors with a p-
value below 0.2 were further evaluated in a multivariate
logistic regression model. Risks were expressed as odds
ratios (ORs) with 95% confidence intervals (95% CIs). P
values less than 0.05 were considered significant. The
SPSS program (Version 10) was used for all analysis.
Results
A total of 788 individuals participated in the study. The
age ranged from 13 to 37 (mean = 21.1, SD = 4.5). TheSports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2009, 1:16 http://www.smarttjournal.com/content/1/1/16
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mean age in the Amenorrhea/Oligomenorrhea group 20.1
± 4.4, and in the eumenorrhea group 21.1 ± 4.5 was
slightly different but was not statistically significant (T
test: t = 0.417, p = 0.677). Table 1 presents the baseline
characteristics of the study population. The mean BMI
were 21.2 ± 2.9 (ranged 13.2 to 41.0). The mean BMI was
not different between two groups; 21.9 ± 4.0, and 21.1 ±
2.7 in the Amenorrhea/Oligomenorrhea and eumenor-
rhea group respectively.
Seventy one (9.0%) individuals had amenorrhea or oli-
gomenorrhea, which oligomenorrhea occurred in 4.2%of
participants. Secondary amenorrhea reported in 4.8%,
and no cases of primary amenorrhea detected.
The mean age of menarche (768 cases) was 13.7 ± 1.6
years, ranged from age of 9 – 20. The mean age of
menarche in the Amenorrhea/Oligomenorrhea group was
13.8 ± 1.9 and in the eumenorrhea group 13.7 ± 1.6,
which was not statistical significant difference (T test: t =
0.143, p = 0.887).
Late-onset menarche occurred in 3.4% (26) of partici-
pants, of which 7.2% was in the Amenorrhea/Oligomen-
orrhea group and 3% in eumenorrhea group. This
difference was statistically significant (Table 2).
Of the 71 participants with Amenorrhea/Oligomenorrhea
whom has been evaluated for polycystic ovary disease,
eleven participants diagnosed with this disease (15.5%).
Association between Amenorrhea/Oligomenorrhea and 
potential risk factors
Table 2 summarizes the relationship of Amenorrhea/Oli-
gomenorrhea to the age, BMI, Late-onset menarche, use of
OCPs and type of sport and intensity of sport. Participants
older than twenty years old were at less risk of Amenor-
rhea/Oligomenorrhea compared to participants younger
OR; 2.67, 95%CI (1.47 – 4.85). Further evaluation in the
multivariate model revealed the same results.
Being thin or fat showed no extra risk of Amenorrhea/Oli-
gomenorrhea in this study (table 2). Late-onset menarche
was a significant risk for Amenorrhea/Oligomenorrhea
(table 2). Further adjustment for type of sport, age, BMI
and use of OCPs did not change the results OR; 3.32,
95%CI (1.04 – 10.51).
In the Amenorrhea/Oligomenorrhea group, twenty one
(28.2%) participants with Amenorrhea/Oligomenorrhea
had used OCPs and one person (1.4%) has used diuretics
and/or weight-reducing drugs. None of this group used
thyroid hormones. In the eumenorrhea group, 63 (8.8%)
participants used OCPs. Sixteen (2.2%), and 15 (2.1%)
participants of this group used diuretics and/or weight-
reducing drugs and thyroid hormones respectively. We
detected no association between diuretics and/or weight-
reducing drugs and amenorrhea/oligomenorrhea OR;
0.63, 95%CI (0.0.08 – 4.79), p-value = 0.652. We found a
positive association between use of OCPs in the last year
and Amenorrhea/Oligomenorrhea, (OR; 6.17 95%CI
(3.00 – 12.69). Adjusted for other factors in the model,
the risk of Amenorrhea/Oligomenorrhea was high in two
Table 1: Baseline characteristics of study population
Amenorrhea/Oligomenorrhea group (n = 71) Eumenorrhea group (n = 717)
BMI < 20 23 (32.9) 245 (34.9)
BMI 20–25 36 (51.4) 398 (56.7)
BMI > 25 11 (15.7) 59 (8.4)
Sport intensity, mean (SD) (hours/week) 14.35 (11.44) 12.64 (10.59)
Level of education
High School undergraduate 16 (22.5) 161 (22.8)
High School graduate 26 (36.6) 242 (34.2)
Bachelors degree 29 (40.8) 304 (43.0)
Types of sport
Other sports (reference) 36 (50.7) 438 (61.1)
subject scored - 29 (4.0)
endurance sports 9 (12.7) 38 (5.3)
body contour 2(2.8) 31 (4.3)
weight categories 24 (33.8) 181 (25.2)
History of Drug intake
OCPs 51 (71.8) 654 (91.2)
Diuretics & weight-reducing drugs 1 (1.4) 16 (2.2)
Thyroid hormones - 15 (2.1)Sports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2009, 1:16 http://www.smarttjournal.com/content/1/1/16
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types of sports; endurance sports (OR; 2.89, 95%CI (1.22
– 6.84) and weight categories (OR; 2.09, 95%CI (1.15 –
3.82).
Discussion
These findings support the previous findings in the litera-
ture that the prevalence of amenorrhea and oligomenor-
rhea is high in athletes. Females practicing endurance and
weight-class sports had a significantly higher risk of these
disorders. There was also a positive association between
the disorders and the following: age under 20 years old,
late onset of menarche, and use of OCPs. Intensity of
training sport or BMI were not risk factors. About one
sixth of the athletes with amenorrhea/oligomenorrhea
were diagnosed as PCOS.
To our knowledge, this is the first study in Iran to evaluate
risk factors of amenorrhea and oligomenorrhea in ath-
letes. A particular strength is its high response rate, which
led to a large sample size. We invited all possible top
female Iranian athletes from 34 sports federations, includ-
ing female medalists in Tehran and female members of
national teams. Very high percentages (95%) were
included in this study. Another strength of this study is
that it presents the prevalence of PCOS in women ath-
letes, which has not been evaluated earlier.
Like earlier studies, we demonstrate that prevalence of
amenorrhea/oligomenorrhea in athletes is high. Having
compared the prevalence of amenorrhea/oligomenorrhea
in our study with the prevalence in the general population
reported in a review by Pfeifer and Patrizio [4], we con-
clude that these disorders are more frequent in athletes.
However, as there are no reliable data on prevalence of
amenorrhea/oligomenorrhea in the Iranian general popu-
lation, we have not been able to compare our data with
those of our population.
Like other studies [1,9,10], we show that amenorrhea/oli-
gomenorrhea occurred significantly more in weight-class
and endurance sports. The probable reason lies in weight-
class athletes' focus on leanness and low body weight.
They believe that the chance of success is higher if they can
participate in the lowest possible weight category. This
very belief leads to increased efforts to losing weight. To
increase their performance, athletes in endurance sports
tend to lose weight.
Unlike other study [9] and a report by the IOC [1], we
detected no association between aesthetic sports and
amenorrhea/oligomenorrhea. The disparity is probably
explained by the fact that only two aesthetic sports were
represented in our study: aerobic sport and vosho. None
of the participants in this group reported any amenorrhea
or oligomenorrhea. No participants did ballet, figure skat-
ing, or synchronized swimming. Menarche had not
started in any of the gymnasts who responded, who were
therefore not included in this study.
In recent years, some studies have reported significant
relationships between menstrual disorders and late-onset
menarche in athletes. In 2007, Micklesfield et al. studied
menstrual disorders in 613 marathon and half-marathon
runners in South Africa [11]. As in our study, they showed
that onset of menarche was later in the group with amen-
orrhea/oligomenorrhea than in the group with regular
Table 2: association between Amenorrhea/Oligomenorrhea and risk factors
OR (95% CI)
Univariate Regression analysis
OR (95% CI)
Multivariate Regression analysis
Age < 20 years 1.58(1–2.57) 2.67 (1.47–4.85)*
BMI 20–25 (reference)
BMI < 20 1.04(0.60–1.79) 0.88 (0.49 – 1.60)
BMI > 25 2.06(1.0–4.27) 1.48(0.62–3.53)
Sport intensity (hours per week) 1.01 (0.99–1.03) 1.02 (0.99–1.04)
Late-onset Menarche 2.52(0.92–6.91) 3.32(1.04–10.51)*
Use of OCPs 4.07(2.28–7.25) 6.17(3.00–12.69)*
Types of sport
Other sports (reference) 1 1
subject scored NA NA
endurance sports 2.89(1.29–6.43) 2.89(1.22–6.84)*
body contour 0.79 (0.18–3.41) 0.20 (0.02–1.71)
weight categories 1.61(0.94–2.78) 2.09(1.15–3.82)*
All analyses were evaluated using the Logistics regression model.
All variable with a p-value < 0.2 in univarriate analysis entered in the multivariate model
* p-value < 0.05 ** p-value < 0.2
NA: Any participants in subject scored group reported Amenorrhea/OligomenorrheaSports Medicine, Arthroscopy, Rehabilitation, Therapy & Technology 2009, 1:16 http://www.smarttjournal.com/content/1/1/16
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menstruation. Menstrual disorders and late onset
menarche both seem to have caused by intensive training
and inadequate energy intake [12]
Our study also shows that participants aged under 20
reported more amenorrhea/oligomenorrhea than older
participants. Readers are reminded that we excluded all
participants who were in their first year of menarche and
who had reported amenorrhea/oligomenorrhea, which
we considered to be a physiological event. The experience
of Iranian obstetricians is that these disorders are more
likely to occur before the age of 20, even in girls who prac-
tice no sport. Their higher prevalence in athletes younger
than 20 years seems to be due not to sporting activities,
but to the immaturity of the girls' reproductive systems.
Although it has been shown that a certain percentage of
fat mass is required for menstruation to begin and to con-
tinue regularly, no specific percentages have been
reported [13,14]. This number seems to vary from person
to person. Unlike other studies, we found no significant
relationship between amenorrhea/oligomenorrhea and
BMI (BMI < 20 and BMI > 25) [15]. The explanation may
lie in the fact that many aesthetic sports which require
extreme leanness (such as ballet, dance, figure-skating,
and synchronized swimming) are not practiced in Iran.
Moreover, the criticism of the use of BMI for body compo-
sition on assessment are that it is a relatively poor predic-
tor of body fat percentage and it results in inaccurate
classifications (normal overweight, obese) for some indi-
viduals [15]. Unfortunately, due to feasibility reason, we
were unable to use more advanced methods such as meas-
urement of skin fold, or bioelectrical impedance analysis
to estimate body fat percentage.
Studies by the International Olympic Committee have
reported a higher prevalence of amenorrhea/oligomenor-
rhea in athletes who seek to improve their physical per-
formance through strict dietary restrictions or through
strenuous exercises intended to induce weight loss [1].
The study by Torstveit et al. also showed that weight-class
athletes use pathologic methods of weight reduction more
than other athletes [9]. Another studies also confirm that
menstrual dysfunction is more prevalent among athletes
who focus on losing weight and becoming thinner [16].
Although Torstveit et al. reported a relationship between
weight-reducing drugs and amenorrhea/oligomenorrhea
[9], we observed no such relationship in our study. This
may have been due to small number of participants who
reported using such drugs. It appears that some partici-
pants may have denied using weight-reducing drugs out
of fear of expulsion from the team, and out of fear of their
parents' and coach's objections, etc.
Although, unlike Drinkwater et al. [17], we found no asso-
ciation between amenorrhea/oligomenorrhea and the
intensity with which sports were practised, our results
agreed with those of two other studies [18,19], which
reported no difference between training intensity among
amenorrhea and eumenorrhea athletes. Because we had
no clear or reliable reports of abrupt onset of intense train-
ing, we could not evaluate whether there was any associa-
tion between the onset of amenorrhea/oligomenorrhea
and a sharp increase in sport intensity.
A review by Loucks et al.[20] in 2006 stated that the prev-
alence of PCOS in women athletes has never been
assessed or reported. To our knowledge, our study is there-
fore the first on the prevalence of PCOS in women ath-
letes. However, we should remind readers that we
assessed PCOS in any participants with clinical symptoms
of amenorrhea/oligomenorrhea, but not in those who
had no mentioned of these disorders. Because some PCOS
cases might show any clinical manifestation, we may have
underestimated the prevalence of PCOS.
Haberland et al. reported in a survey in 1995 that over
90% of sports medicine doctors or family physicians pre-
scribed estrogen replacement to treat athletic amenorrhea
[21] The positive association we found between amenor-
rhea/oligomenorrhea and the use of OCPs might there-
fore be due to the prescription of OCPs for treating
menstrual irregularities.
It should be pointed out that this study evaluated Iranian
female athletes in organized sport federations. As stated
above, the variety and frequency of these sports was not
necessarily the same as those of leading women's sports in
other countries: for example, ballet, figure skating, and
synchronized swimming are not represented in any sport
club in Iran. Although women's sports have been brought
some difficulties by Islamic dress codes, they are nonethe-
less progressing slowly and steadily. As the number of pro-
fessional women's clubs is very low, there are not many
high-level competitions; similarly, international competi-
tion is subject to considerable limitation. We believe that
the difference between our results and those of studies in
non-Islamic countries are partly a consequence of these
differences.
Future studies among Iranian female athletes should
examine preventable risks, such as inappropriate dietary
restrictions, pathologic methods of weight loss, psycho-
logical and physical stress, and athlete's personality types.
Conclusion
In conclusion, to increase awareness risks of menstrual
disorder-related exercise, it is necessary to design com-
plete and comprehensive education programs for femalePublish with BioMed Central    and   every 
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athletes, their parents, their coaches, and the relevant
authorities. There should be a greater focus on weight-
class and endurance sports in Iran, and especially on their
associations with the so-called female athlete triad (eating
disorders, amenorrhea and osteoporosis). Since many
athletes deny eating disorders, and since diagnosis of oste-
oporosis needs paraclinical investigation, amenorrhea/
oligomenorrheaprovides the best starting point for detect-
ing this triad. On the other hand, these disorders can
themselves lead to other disorders, such as osteoporosis
and stress fracture. Athletes would be greatly benefited by
greater general awareness about the complications of
amenorrhea/oligomenorrhea.
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